DOV vs INBX · P/E 27, rev $4.24B vs rev $1.3M
Dover Corporation (DOV) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. INBX currently screens at market cap $1.28B.
Not investment advice. Open the DOV and INBX stock pages for the full models.
Not investment advice.